Performance of CT in the Preoperative Diagnosis of Cervical Lymph Node Metastasis in Patients with Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis

References

1. 1.↵
   2. Mulla M,
   3. Schulte KM

   . Central cervical lymph node metastases in papillary thyroid cancer: a systematic review of imaging-guided and prophylactic removal of the central compartment. Clin Endocrinol (Oxf) 2012;76:131–36 doi:10.1111/j.1365-2265.2011.04162.x pmid:21722150

   CrossRefPubMed
2. 2.↵
   2. Rotstein L

   . The role of lymphadenectomy in the management of papillary carcinoma of the thyroid. J Surg Oncol 2009;99:186–88 doi:10.1002/jso.21234 pmid:19170045

   CrossRefPubMed
3. 3.↵
   2. Sivanandan R,
   3. Soo KC

   . Pattern of cervical lymph node metastases from papillary carcinoma of the thyroid. Br J Surg 2001;88:1241–44 doi:10.1046/j.0007-1323.2001.01843.x pmid:11531874

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Randolph GW,
   3. Duh QY,
   4. Heller KS, et al

   ; American Thyroid Association Surgical Affairs Committee's Taskforce on Thyroid Cancer Nodal Surgery. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 2012;22:1144–52 doi:10.1089/thy.2012.0043 pmid:23083442

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Zaydfudim V,
   3. Feurer ID,
   4. Griffin MR, et al

   . The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 2008;144:1070–77; discussion 77–78; discussion 1077–78 doi:10.1016/j.surg.2008.08.034 pmid:19041020

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Mazzaferri EL,
   3. Doherty GM,
   4. Steward DL

   . The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid 2009;19:683–89 doi:10.1089/thy.2009.1578 pmid:19583485

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Haugen BR,
   3. Alexander EK,
   4. Bible KC, et al

   . 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016;26:1–133 doi:10.1089/thy.2015.0020 pmid:26462967

   CrossRefPubMed
8. 8.↵
   2. Wu LM,
   3. Gu HY,
   4. Qu XH, et al

   . The accuracy of ultrasonography in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: a meta-analysis. Eur J Radiol 2012;81:1798–805 doi:10.1016/j.ejrad.2011.04.028 pmid:21536396

   CrossRefPubMed
9. 9.↵
   2. Ito Y,
   3. Jikuzono T,
   4. Higashiyama T, et al

   . Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg 2006;30:1821–28 doi:10.1007/s00268-006-0211-5 pmid:16983469

   CrossRefPubMed
10. 10.↵
    2. Sipos JA

    . Advances in ultrasound for the diagnosis and management of thyroid cancer. Thyroid 2009;19:1363–72 doi:10.1089/thy.2009.1608 pmid:20001718

    CrossRefPubMed
11. 11.↵
    2. Hwang HS,
    3. Orloff LA

    . Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer. Laryngoscope 2011;121:487–91 doi:10.1002/lary.21227 pmid:21344423

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Ha EJ,
    3. Baek JH,
    4. Lee JH

    . Ultrasonography-based thyroidal and perithyroidal anatomy and its clinical significance. Korean J Radiol 2015;16:749–66 doi:10.3348/kjr.2015.16.4.749 pmid:26175574

    CrossRefPubMed
13. 13.↵
    2. Cooper DS,
    3. Doherty GM,
    4. Haugen BR, et al

    ; American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167–214 doi:10.1089/thy.2009.0110 pmid:19860577

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Jeong HS,
    3. Baek CH,
    4. Son YI, et al

    . Integrated 18F-FDG PET/CT for the initial evaluation of cervical node level of patients with papillary thyroid carcinoma: comparison with ultrasound and contrast-enhanced CT. Clin Endocrinol (Oxf) 2006;65:402–07 doi:10.1111/j.1365-2265.2006.02612.x pmid:16918964

    CrossRefPubMed
15. 15.↵
    2. Ahn JE,
    3. Lee JH,
    4. Yi JS, et al

    . Diagnostic accuracy of CT and ultrasonography for evaluating metastatic cervical lymph nodes in patients with thyroid cancer. World J Surg 2008;32:1552–58 doi:10.1007/s00268-008-9588-7 pmid:18408961

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Kim E,
    3. Park JS,
    4. Son KR, et al

    . Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography. Thyroid 2008;18:411–18 doi:10.1089/thy.2007.0269 pmid:18358074

    CrossRefPubMed
17. 17.↵
    2. Choi JS,
    3. Kim J,
    4. Kwak JY, et al

    . Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT. AJR Am J Roentgenol 2009;193:871–78 doi:10.2214/AJR.09.2386 pmid:19696304

    CrossRefPubMed
18. 18.↵
    2. Choi YJ,
    3. Yun JS,
    4. Kook SH, et al

    . Clinical and imaging assessment of cervical lymph node metastasis in papillary thyroid carcinomas. World J Surg 2010;34:1494–99 doi:10.1007/s00268-010-0541-1 pmid:20372903

    CrossRefPubMed
19. 19.↵
    2. Lee DW,
    3. Ji YB,
    4. Sung ES, et al

    . Roles of ultrasonography and computed tomography in the surgical management of cervical lymph node metastases in papillary thyroid carcinoma. Eur J Surg Oncol 2013;39:191–96 doi:10.1016/j.ejso.2012.07.119 pmid:22863305

    CrossRefPubMed
20. 20.↵
    2. Lesnik D,
    3. Cunnane ME,
    4. Zurakowski D, et al

    . Papillary thyroid carcinoma nodal surgery directed by a preoperative radiographic map utilizing CT scan and ultrasound in all primary and reoperative patients. Head Neck 2014;36:191–202 doi:10.1002/hed.23277 pmid:23554058

    CrossRefPubMed
21. 21.↵
    2. Liu X,
    3. Ouyang D,
    4. Li H, et al

    . Papillary thyroid cancer: dual-energy spectral CT quantitative parameters for preoperative diagnosis of metastasis to the cervical lymph nodes. Radiology 2015;275:167–76 doi:10.1148/radiol.14140481 pmid:25521777

    CrossRefPubMed
22. 22.↵
    2. Na DK,
    3. Choi YJ,
    4. Choi SH, et al

    . Evaluation of cervical lymph node metastasis in thyroid cancer patients using real-time CT-navigated ultrasonography: preliminary study. Ultrasonography 2015;34:39–44 doi:10.14366/usg.14030 pmid:25327528

    CrossRefPubMed
23. 23.↵
    2. Yeh MW,
    3. Bauer AJ,
    4. Bernet VA, et al

    ; American Thyroid Association Surgical Affairs Committee Writing Task Force. American Thyroid Association statement on preoperative imaging for thyroid cancer surgery. Thyroid 2015;25:3–14 doi:10.1089/thy.2014.0096 pmid:25188202

    CrossRefPubMed
24. 24.↵
    2. Tunis AS,
    3. McInnes MD,
    4. Hanna R, et al

    . Association of study quality with completeness of reporting: have completeness of reporting and quality of systematic reviews and meta-analyses in major radiology journals changed since publication of the PRISMA statement? Radiology 2013;269:413–26 doi:10.1148/radiol.13130273 pmid:23824992

    CrossRefPubMed
25. 25.↵
    2. Suh CH,
    3. Park SH

    . Successful publication of systematic review and meta-analysis of studies evaluating diagnostic test accuracy. Korean J Radiol 2016;17:5–6 doi:10.3348/kjr.2016.17.1.5 pmid:26798211

    CrossRefPubMed
26. 26.↵
    2. Kim KW,
    3. Lee J,
    4. Choi SH, et al

    . Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers, part I: general guidance and tips. Korean J Radiol 2015;16:1175–87 doi:10.3348/kjr.2015.16.6.1175 pmid:26576106

    CrossRefPubMed
27. 27.↵
    2. Lee J,
    3. Kim KW,
    4. Choi SH, et al

    . Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers, part II, statistical methods of meta-analysis. Korean J Radiol 2015;16:1188–96 doi:10.3348/kjr.2015.16.6.1188 pmid:26576107

    CrossRefPubMed
28. 28.↵
    1. Edge S,
    2. Byrd DR,
    3. Compton CC, et al.

    , eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010:87–96
29. 29.↵
    2. Som PM,
    3. Brandwein M,
    4. Lidov M, et al

    . The varied presentations of papillary thyroid carcinoma cervical nodal disease: CT and MR findings. AJNR Am J Neuroradiol 1994;15:1123–28 pmid:8073982

    Abstract/FREE Full Text
30. 30.↵
    2. Na DG,
    3. Lim HK,
    4. Byun HS, et al

    . Differential diagnosis of cervical lymphadenopathy: usefulness of color Doppler sonography. AJR Am J Roentgenol 1997;168:1311–16 doi:10.2214/ajr.168.5.9129432 pmid:9129432

    CrossRefPubMed
31. 31.↵
    2. Ying M,
    3. Ahuja A,
    4. Metreweli C

    . Diagnostic accuracy of sonographic criteria for evaluation of cervical lymphadenopathy. J Ultrasound Med 1998;17:437–45 pmid:9669302

    Abstract
32. 32.↵
    2. Rosário PW,
    3. de Faria S,
    4. Bicalho L, et al

    . Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma. J Ultrasound Med 2005;24:1385–89 pmid:16179622

    Abstract/FREE Full Text
33. 33.↵
    2. Whiting P,
    3. Rutjes AW,
    4. Reitsma JB, et al

    . The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25 doi:10.1186/1471-2288-3-25 pmid:14606960

    CrossRefPubMed
34. 34.↵
    2. Higgins J,
    3. Green S

    . Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. Updated March 2011. http://handbook.cochrane.org/. Accessed August 15, 2015.
35. 35.↵
    2. Deeks JJ,
    3. Macaskill P,
    4. Irwig L

    . The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 2005;58:882–93 doi:10.1016/j.jclinepi.2005.01.016 pmid:16085191

    CrossRefPubMedWeb of Science
36. 36.↵
    2. Spate VL,
    3. Morris JS,
    4. Nichols TA, et al

    . Longitudinal study of iodine in toenails following IV administration of an iodine-containing contrast agent. Journal of Radioanalytical and Nuclear Chemistry 1998;236:71–77 doi:10.1007/BF02386320

    CrossRef
37. 37.↵
    2. Padovani RP,
    3. Kasamatsu TS,
    4. Nakabashi CC, et al

    . One month is sufficient for urinary iodine to return to its baseline value after the use of water-soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy. Thyroid 2012;22:926–30 doi:10.1089/thy.2012.0099 pmid:22827435

    CrossRefPubMed
38. 38.↵
    2. Sohn SY,
    3. Choi JH,
    4. Kim NK, et al

    . The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment. Thyroid 2014;24:872–77 doi:10.1089/thy.2013.0238 pmid:24295076

    CrossRefPubMed
39. 39.↵
    2. Ho JD,
    3. Tsang JF,
    4. Scoggan KA, et al

    . Urinary iodine clearance following iodinated contrast administration: a comparison of euthyroid and postthyroidectomy subjects. J Thyroid Res 2014;2014:580569 doi:10.1155/2014/580569 pmid:25478285

    CrossRefPubMed
40. 40.↵
    2. Mishra A,
    3. Pradhan PK,
    4. Gambhir S, et al

    . Preoperative contrast-enhanced computerized tomography should not delay radioiodine ablation in differentiated thyroid carcinoma patients. J Surg Res 2015;193:731–37 doi:10.1016/j.jss.2014.07.065 pmid:25193578

    CrossRefPubMed
41. 41.↵
    2. Tala Jury HP,
    3. Castagna MG,
    4. Fioravanti C, et al

    . Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients. J Clin Endocrinol Metab 2010;95:230–37 doi:10.1210/jc.2009-1624 pmid:19858316

    CrossRefPubMed
42. 42.↵
    2. Liberati A,
    3. Altman DG,
    4. Tetzlaff J, et al

    . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100 doi:10.1371/journal.pmed.1000100 pmid:19621070

    CrossRefPubMed
43. 43.↵
    1. Deeks JJ,
    2. Bossuyt PM,
    3. Gatsonis C

    , eds. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Version 1.0.0Accessed March 31, 2016. The Cochrane Collaboration. 2013. http://srdta.cochrane.org/handbook-dta-reviews. Accessed March 31, 2016.
44. 44.↵
    2. Trikalinos TA,
    3. Balion CM,
    4. Coleman CI, et al

    . Chapter 8: meta-analysis of test performance when there is a “gold standard.” J Gen Intern Med 2012;27(suppl 1):S56–66 doi:10.1007/s11606-012-2029-1 pmid:22648676

    CrossRefPubMed